Target intelligence / Profile preview

Novel protein pseudogene

Molecular classification
Pseudogene, Processed pseudogene
01

Overview

Novel protein pseudogene" (ENSG00000288567) refers to a **pseudogene**, which is a DNA segment that resembles a functional protein-coding gene but is generally nonfunctional due to sequence disruptions (such as frame shifts or premature stop codons) or lack of regulatory elements required for gene expression[1][2][3]. Pseudogenes can be created by duplication or retrotransposition but nearly always lack protein-coding capacity. While extremely rare pseudogenes may be expressed and exert regulatory or even protein functions, in almost all cases—including the general category "novel protein pseudogene"—these are nonfunctional genetic elements[2][3]. Large-scale surveys indicate pseudogenes are prevalent throughout the genome and may sometimes be misannotated as functional genes in sequence databases[2][3]. Context: - "Novel protein pseudogene" is a general genome annotation, not a specific receptor, enzyme, or molecular target. - *ENSG00000288567* is listed as a pseudogene because it shares sequence similarity to known protein-coding genes but lacks evidence for producing a functional protein[1][3]. - Pseudogenes are common in the human genome (~12,000–14,000 identified), and many are remnants of past duplication or retrotransposition events[2][3]. - They are typically not considered druggable targets or associated with established roles in disease or therapeutics, though an extremely small subset have regulatory RNA roles[4].

02

Biological functions

None (Pseudogenes do not have canonical biological functions as proteins or regulatory RNAs, although some rare pseudogenes may exert regulatory effects[4].)
03

Disease associations

Other (In general, pseudogenes are not directly associated with disease, though rare regulatory roles have been described in the literature[4].)

Beyond the preview

Go deeper on Novel protein pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel protein pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call